Videos

Featured

SUCCESS PTA: 12-Month Data from SELUTION SLR™ DEB

Michael Lichtenberg

Watch time: 4m 19s

Broadcast

Vascular Disease and Surgery
Advanced Vascular Conference 2025 Webinar

Konstantinos P Donas, Drosos Kotelis, Grigorios Korosoglou, et al

Watch time: 47m 21s
IN.PACT AV Access: Demographic Data from Post Approval Study

Sanjay Misra

Watch time: 5m 8s
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX

Marianne Brodmann

Watch time: 3m 41s
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold

David Power

Watch time: 6m 52s
AHA 24: New Insights from CLEAR OUTCOMES

Marc P Bonaca

Watch time: 3m 49s

Michael Lichtenberg

TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty

Ulf Teichgräber

Watch time: 7m 10s

Broadcast

Vascular Disease and Surgery
Spur RST: Maximizing BTK CLTI Treatment Outcomes

Michael Lichtenberg, Thomas Zeller, Andrej Schmidt, et al

Watch time: 52m 56s

Trending

TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s

Michael Lichtenberg

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)

Michael Lichtenberg

Watch time: 2m 39s (19 videos)

Stephen Black, Frank Arko, Koen Deloose, et al

Watch time: 11h 38m 9s (13 videos)
ESC 25: The CARUSO Trial

Tiziana Claudia Aranzulla

Watch time: 7m 20s

Stephen Black, Gregory Magee, Bijan Modarai, et al

Watch time: 14h 30m 38s (9 videos)

Jeffrey Weitz, Carolyn Lam, Davide Capodanno, et al

Watch time: 47m 57s (6 videos)

Scott O Trerotola, Marianne Brodmann, Matteo Tozzi, et al

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Events

Filter by

TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial

Michael J Mack

Watch time: 10m 32s
TCT 25: The PREVUE-VALVE Study

David J Cohen

Watch time: 7m 2s
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s
CIRSE 25: 12 Month Outcomes from the SUCCESS PTA Study

Michael Lichtenberg

Watch time: 5m 19s
CIRSE 25: The CAIN Trial

Tze Min Wah

Watch time: 4m 41s
EASD 2025: Semaglutide and Risk Reduction of Major Adverse Limb Events in Diabetes

Subodh Verma

Watch time: 12m 9s
CIRSE 25: The BIONETIC-I Study

Marianne Brodmann

Watch time: 5m 10s
The Amber Peripheral Liquid Embolic System

Fernando Gómez Muñoz

Watch time: 3m 39s
ESC 25 Discussion: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

Harriette Van Spall, Michael Andrew Borger

Watch time: 14m 30s
ESC 25: SWEDEPAD 1 and 2

Marten Falkenberg, Joakim Nordanstig

Watch time: 6m 35s

Latest

Filter by

TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial

Michael J Mack

Watch time: 10m 32s
TCT 25: The PREVUE-VALVE Study

David J Cohen

Watch time: 7m 2s
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s

Rahul Aggarwal, Dirk Müller-Wieland

Watch time: 20m 22s (2 videos)
CIRSE 25: 12 Month Outcomes from the SUCCESS PTA Study

Michael Lichtenberg

Watch time: 5m 19s
CIRSE 25: The CAIN Trial

Tze Min Wah

Watch time: 4m 41s
EASD 2025: Semaglutide and Risk Reduction of Major Adverse Limb Events in Diabetes

Subodh Verma

Watch time: 12m 9s
CIRSE 25: The BIONETIC-I Study

Marianne Brodmann

Watch time: 5m 10s